FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutical industry and represents a method of treating ptosis in an individual, involving administration of an effective amount of oxymetazoline or its pharmaceutically acceptable salts and an effective amount of phenylephrine or its pharmaceutically acceptable salt into an external surface of eye of an individual in need of the above treatment.
EFFECT: invention ensures the absence of clinically significant mydriasis and the improved field of vision.
24 cl, 3 dwg, 7 tbl, 10 ex
| Title |
Year |
Author |
Number |
| METHODS AND COMPOSITIONS FOR TREATING PRESBYOPIA, MYDRIASIS AND OTHER OCULAR DISORDERS |
2019 |
- Pitlick, William H.
- Meyer, Alan R.
- Sooch, Mina
- Charizanis, Konstantinos
- Hoffmann, Bernhard
|
RU2824137C2 |
| OXYMETAZOLINE COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERS |
2020 |
- Devries, Tina
- Jacobs, David
|
RU2820596C2 |
| OPHTHALMIC COMPOSITION AND A METHOD FOR AMELEORATING PRESBYOPIA |
2013 |
- Vekharano Restrepo Luis Felipe
|
RU2657514C2 |
| DRUGS AND METHODS FOR TREATMENT OF PRESBYOPIA, MODERATE HYPERMETROPY AND INCORRECT ASYGMATICISM |
2012 |
|
RU2630968C2 |
| COMBINATION OF FOLIC ACID AND RAMIPRIL: CYTOPROTECTIVE, NEUROPROTECTIVE AND RETINOPROTECTIVE OPHTHALMIC COMPOSITIONS |
2011 |
|
RU2602738C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES |
2016 |
- Jain, Sandeep
- Kompella, Uday, Bhaskar
- Musunuri, Shankar
|
RU2691412C2 |
| ANTI-INFLAMMATORY AND MYDRIATIC INTRA-CHAMBER SOLUTIONS FOR INHIBITION OF POSTOPERATIVE INFLAMMATORY EYE CONDITIONS |
2015 |
- Demopulos, Gregory, A.
- Florio, Vincent, A.
|
RU2750296C2 |
| METHOD OF PREVENTING OR TREATING SKIN TUMOUR |
2011 |
- Buve Gi
- Leoni Mettyu Dzhejms
- Graber Majkl
|
RU2587041C2 |
| PROSTAGLANDIN F2 ALPHA AND ITS ANALOGUES FOR TREATING ATROPHIC SKIN SCARRING |
2014 |
|
RU2690183C2 |
| USING ALPHA 2 ADRENERGIC RECEPTOR AGONISTS FOR TREATING OR PREVENTING PSORIASIS |
2010 |
|
RU2538729C2 |
